Metastatic renal cell carcinoma can affect the body in different ways depending on the location it has spread to. Learn more here.

Renal cell carcinoma articles from across Nature Portfolio Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney.

Renal cell carcinoma is a common type of cancer that affects the kidneys. Learn more here.

Immune-checkpoint inhibitors have revolutionized the management of hepatocellular carcinoma. Currently, anti-PD-(L)-1 antibodies combined with either bevacizumab or anti-CTLA4 antibodies are the ...

Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma ...

This document, on the diagnosis and treatment of patients with hepatocellular carcinoma (HCC), was commissioned by the British Society of Gastroenterology as part of a wider initiative to develop ...

ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.

Salivary gland cancer is a disease in which cancerous cells are found in one of three main types of salivary glands.

After someone is diagnosed with endometrial cancer, doctors will try to figure out if it has spread and, if so, how far. This process is called staging.

Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic ...